149 related articles for article (PubMed ID: 37269078)
1. Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.
Cannon A; Sarin KY; Petersen AK; Pichard DC; Wolters PL; Erickson G; Lessing AJ; Li P; Röhl C; Rosser T; Widemann BC; Blakeley JO; Plotkin SR
Clin Trials; 2024 Feb; 21(1):67-72. PubMed ID: 37269078
[TBL] [Abstract][Full Text] [Related]
2. Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials.
Cannon A; Pichard DC; Wolters PL; Adsit S; Erickson G; Lessing AJ; Li P; Narmore W; Röhl C; Rosser T; Widemann BC; Blakeley JO; Plotkin SR;
Neurology; 2021 Aug; 97(7 Suppl 1):S15-S24. PubMed ID: 34230202
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.
Cannon A; Chen MJ; Li P; Boyd KP; Theos A; Redden DT; Korf B
Orphanet J Rare Dis; 2018 Feb; 13(1):31. PubMed ID: 29415745
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinicopathological characteristics of lipomatous neurofibromas in neurofibromatosis 1: An investigation of 229 cutaneous neurofibromas and a systematic review of the literature.
Rozza-de-Menezes RE; Brum CAI; Gaglionone NC; de Sousa Almeida LM; Andrade-Losso RM; Paiva BVB; Faveret PLS; da Silva AV; Siqueira OHK; Riccardi VM; Cunha KS
J Cutan Pathol; 2018 Oct; 45(10):743-753. PubMed ID: 29959804
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous neurofibromas: patients' medical burden, current management and therapeutic expectations: results from an online European patient community survey.
Guiraud M; Bouroubi A; Beauchamp R; Bocquet A; Grégoire JM; Rauly-Lestienne I; Blanco I; Wolkenstein P; Schmitt AM
Orphanet J Rare Dis; 2019 Dec; 14(1):286. PubMed ID: 31801570
[TBL] [Abstract][Full Text] [Related]
6. Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas.
Ly I; Romo CG; Gottesman S; Kelly KM; Kornacki D; York Z; Lee SY; Rhodes SD; Staedtke V; Steensma MR; Blakeley JO; Wolkenstein P
J Invest Dermatol; 2023 Aug; 143(8):1388-1396. PubMed ID: 37294242
[TBL] [Abstract][Full Text] [Related]
7. Melanocytic nevi are associated with neurofibromas in neurofibromatosis, type I, but not sporadic neurofibromas: a study of 226 cases.
Ball NJ; Kho GT
J Cutan Pathol; 2005 Sep; 32(8):523-32. PubMed ID: 16115049
[TBL] [Abstract][Full Text] [Related]
8. Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report.
Sassi I; Bouida MA; Hasnaoui A; Zemni I; Ben Dhieb T
J Med Case Rep; 2024 Jan; 18(1):15. PubMed ID: 38216958
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous neurofibromas: Current clinical and pathologic issues.
Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
[TBL] [Abstract][Full Text] [Related]
10. [Cosmetic and functional results after resection of cutaneous neurofibroma in neurofibromatosis type 1 : Operation of neurofibroma improves quality of life while having moderate complications].
Walz B; Pfefferle V; Häfner HM; Kofler L
Dermatologie (Heidelb); 2022 Dec; 74(12):961-968. PubMed ID: 37728798
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.
Merker VL; Thompson HL; Wolters PL; Buono FD; Hingtgen CM; Rosser T; Barton B; Barnett C; Smith T; Haberkamp D; McManus ML; Baldwin A; Moss IP; Röhl C; Martin S
Clin Trials; 2024 Feb; 21(1):6-17. PubMed ID: 38140900
[TBL] [Abstract][Full Text] [Related]
12. Eruptive neurofibromas in pregnancy.
Yahya H; Sani H
Ann Afr Med; 2020; 19(2):150-152. PubMed ID: 32499474
[TBL] [Abstract][Full Text] [Related]
13. Vascular wall cells contribute to tumourigenesis in cutaneous neurofibromas of patients with neurofibromatosis type 1. A comparative histological, ultrastructural and immunohistochemical study.
Friedrich RE; Holstein AF; Middendorff R; Davidoff MS
Anticancer Res; 2012 May; 32(5):2139-58. PubMed ID: 22593502
[TBL] [Abstract][Full Text] [Related]
14. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
[TBL] [Abstract][Full Text] [Related]
15. Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life.
Wolters PL; Burns KM; Martin S; Baldwin A; Dombi E; Toledo-Tamula MA; Dudley WN; Gillespie A; Widemann BC
Am J Med Genet A; 2015 Sep; 167A(9):2103-13. PubMed ID: 25976979
[TBL] [Abstract][Full Text] [Related]
16. Sporadic and multiple neurofibromas in the head and neck region: a retrospective study of 33 years.
Marocchio LS; Oliveira DT; Pereira MC; Soares CT; Fleury RN
Clin Oral Investig; 2007 Jun; 11(2):165-9. PubMed ID: 17285268
[TBL] [Abstract][Full Text] [Related]
17. [Neurofibromas in Type I Neurofibromatosis. Description of a clinical case and literature review].
Del Puerto C; Aspee M; Downey C
Andes Pediatr; 2022 Oct; 93(5):741-748. PubMed ID: 37906895
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative aspects of mast cells in normal skin and in neurofibromas of neurofibromatosis types 1 and 5.
Nürnberger M; Moll I
Dermatology; 1994; 188(4):296-9. PubMed ID: 8193404
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients.
Friedrich RE; Hagel C; Brehme Z; Kluwe L; Mautner VF
Anticancer Res; 2003; 23(2A):953-5. PubMed ID: 12820329
[TBL] [Abstract][Full Text] [Related]
20. Miniature Palpebral Plexiform Neurofibroma in Neurofibromatosis Type 2.
Charles NC; Kim ET
Ophthalmic Plast Reconstr Surg; 2023 Nov-Dec 01; 39(6):e186-e188. PubMed ID: 37338324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
